XML 58 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Long-Term Investments (Details) - Schedule of ownership percentages of investee
 9 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Braingenesis Biotechnology Co., Ltd. [Member]    
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items]    
Ownership percentage 0.17% 0.17%
Accounting treatments Cost Method  
Genepharm Biotech Corporation [Member]    
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items]    
Ownership percentage 0.70% 0.70%
Accounting treatments Cost Method  
BioHopeKing Corporation [Member]    
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items]    
Ownership percentage 5.90% 5.90%
Accounting treatments Cost Method  
BioFirst Corporation [Member]    
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items]    
Ownership percentage 15.99% 15.99%
Accounting treatments Equity Method  
Rgene Corporation [Member]    
Long-Term Investments (Details) - Schedule of ownership percentages of investee [Line Items]    
Ownership percentage 31.62% 31.62%
Accounting treatments Equity Method